
Ultramox CV 1000mg/200mg Injection
Marketer
Ultratech Pharmaceuticals
Salt Composition
Amoxycillin (1000mg) + Clavulanic Acid (200mg)
Overview Ultramox CV 1000mg/200mg Injection
Penbritin-C 1000mg/200mg Injection, a penicillin-based antibiotic, combats bacterial infections. It effectively treats infections in the lungs (pneumonia, for example), ears, sinuses, urinary tract, skin, and soft tissues. This medication is ineffective against viral infections like the common cold. Administration must be by a healthcare provider; self-injection is prohibited. Dosage and frequency are determined by your physician based on your condition's severity and must be strictly followed. Typical side effects include nausea, vomiting, diarrhea, and oral thrush; injection site reactions such as pain, swelling, or redness may also occur. Persistent or worsening side effects warrant immediate medical attention. Patients with severe liver or kidney impairment should consult their doctor before commencing treatment. Prior to use, disclose any antibiotic allergies or pre-existing kidney or liver conditions to your physician, who may adjust the dosage or prescribe an alternative. Under medical supervision, this injection is generally considered safe during pregnancy and breastfeeding.
Uses of Ultramox CV 1000mg/200mg Injection
Preventing bacterial infections related to surgical procedures
Major Benefits of Ultramox CV 1000mg/200mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Ultramox CV 1000mg/200mg Injection:
- Vomiting
- Nausea
- Diarrhea
- Thrush
How to use Ultramox CV 1000mg/200mg Injection:
Administering this medication will be done by your physician or their designated nurse; self-medication is strictly prohibited.
How Ultramox CV 1000mg/200mg Injection works:
Ultramox CV Injection (1000mg amoxicillin/200mg clavulanate) combines the antibiotic amoxicillin with the beta-lactamase inhibitor clavulanic acid. Amoxicillin's antibacterial action disrupts bacterial cell wall synthesis, vital for bacterial viability. Clavulanic acid counteracts bacterial resistance mechanisms, thereby boosting amoxicillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
No adverse reactions are associated with the concomitant use of alcohol and Ultramox CV 1000mg/200mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication, Ultramox CV 1000mg/200mg, is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nonetheless, clinical data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Administering Ultramox CV 1000mg/200mg Injection while breastfeeding presents minimal risk. Research in humans indicates negligible transfer of the medication into breast milk, posing no apparent danger to the infant.
DrivingUNSAFE
Administering Ultramox CV 1000mg/200mg Injection may result in adverse reactions impacting driving aptitude. These reactions can include allergic responses, vertigo, or seizures, rendering operation of a vehicle unsafe.
KidneyCAUTION
The antibiotic Ultramox CV 1000mg/200mg Injection requires careful administration for individuals with impaired renal function. Dosage modification might be necessary. Physician consultation is advised. This injection is contraindicated in patients exhibiting severe kidney disease.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Ultramox CV 1000mg/200mg Injection. Dosage modification may be necessary. Physician consultation is advised. Routine monitoring of liver function is recommended during treatment.
What if you forget to take Ultramox CV 1000mg/200mg Injection :
Should you forget a scheduled dose of Ultramox CV 1000mg/200mg Injection, administer it at your earliest convenience. However, if your next dose is imminent, omit the missed injection and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Ultramox CV 1000mg/200mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
